1. Teriflunomide linked with new onset and worsening of psoriasis

   News item 23 May 2020 Pages: 1 - 1

2. US guidance issued for postmarketing AE reporting during pandemic

   News item 23 May 2020 Pages: 2 - 2

3. Acute kidney injury with SGLT2 inhibitors in elderly patients

   Clinical study 23 May 2020 Pages: 3 - 3

4. AE system developed for Twitter has poor transferability

   Clinical study 23 May 2020 Pages: 4 - 4

5. AEs increase economic burden in patients with CLL

   Clinical study 23 May 2020 Pages: 5 - 5

6. Clozapine no less safe than other antipyschotics during preganancy

   Clinical study 23 May 2020 Pages: 6 - 6

7. Communicating adverse drug reactions to patients

   Clinical study 23 May 2020 Pages: 7 - 7

8. Effect of FDA boxed warning on fluoroquinolone stewardship

   Clinical study 23 May 2020 Pages: 8 - 8

9. Infliximab: elevated risk of psychiatric adverse events

   Clinical study 23 May 2020 Pages: 9 - 9

10. Paradoxical ADR reports in French PharmacoVigilance DataBase

    Clinical study 23 May 2020 Pages: 10 - 10

11. Primary adrenal insufficiency with immune checkpoint inhibitors

    Clinical study 23 May 2020 Pages: 11 - 11

12. Other adverse reaction research

    News item 23 May 2020 Pages: 12 - 12

13. Abatacept/methotrexate

    Case report 23 May 2020 Pages: 13 - 13

14. ACE inhibitor/deferoxamine

    Case report 23 May 2020 Pages: 14 - 14

15. Acenocoumarol/dabigatran-etexilate

    Case report 23 May 2020 Pages: 15 - 15

16. Acetylcysteine/paracetamol

    Case report 23 May 2020 Pages: 16 - 16

17. Adalimumab

    Case report 23 May 2020 Pages: 17 - 17

18. Alendronic-acid/zoledronic-acid

    Case report 23 May 2020 Pages: 18 - 18

19. Alteplase

    Case report 23 May 2020 Pages: 19 - 19

20. Amikacin

    Case report 23 May 2020 Pages: 20 - 20

21. Amiodarone

    Case report 23 May 2020 Pages: 21 - 21

22. Amitriptyline

    Case report 23 May 2020 Pages: 22 - 22

23. Amlodipine overdose

    Case report 23 May 2020 Pages: 23 - 23

24. Amlodipine/antihyperglycaemics/irbesartan

    Case report 23 May 2020 Pages: 24 - 24

25. Amoxicillin/clavulanic-acid

    Case report 23 May 2020 Pages: 25 - 25

26. Amphotericin-B

    Case report 23 May 2020 Pages: 26 - 26

27. Amphotericin-B-liposomal/Cefepime

    Case report 23 May 2020 Pages: 27 - 27

28. Andexanet-α

    Case report 23 May 2020 Pages: 28 - 28

29. Anti-motility agents/capecitabine

    Case report 23 May 2020 Pages: 29 - 29

30. Antibacterials

    Case report 23 May 2020 Pages: 30 - 30

31. Antibiotics

    Case report 23 May 2020 Pages: 31 - 31

32. Antihyperglycaemics

    Case report 23 May 2020 Pages: 32 - 32

33. Antineoplastics

    Case report 23 May 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 23 May 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 23 May 2020 Pages: 35 - 35

36. Antineoplastics

    Case report 23 May 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 23 May 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 23 May 2020 Pages: 38 - 38

39. Antineoplastics/folinic acid

    Case report 23 May 2020 Pages: 39 - 39

40. Antineoplastics/folinic-acid

    Case report 23 May 2020 Pages: 40 - 40

41. Antineoplastics/heparin/unspecified recombinant tissue plasminogen activator

    Case report 23 May 2020 Pages: 41 - 41

42. Antineoplastics/immunosuppressants

    Case report 23 May 2020 Pages: 42 - 42

43. Antirheumatics

    Case report 23 May 2020 Pages: 43 - 43

44. Antithrombin-iii/aspirin/dextran/heparin/plasma

    Case report 23 May 2020 Pages: 44 - 44

45. Aphanizomenon-flos-aquae

    Case report 23 May 2020 Pages: 45 - 45

46. Apixaban

    Case report 23 May 2020 Pages: 46 - 46

47. Apremilast

    Case report 23 May 2020 Pages: 47 - 47

48. Aripiprazole

    Case report 23 May 2020 Pages: 48 - 48

49. Aripiprazole

    Case report 23 May 2020 Pages: 49 - 49

50. Ascorbic-acid/glucose/nicotinamide/pyridoxine/riboflavin/thiamine/Azd3965/glucose

    Case report 23 May 2020 Pages: 50 - 50